High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.3M
$1,279,812
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
Other
|
2026-02-19 | $617,018 | M | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-19 | $37,959 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-19 | $38,775 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-19 | $41,259 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-19 | $162,146 | S | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
Zoghbi Huda Y
• Director
10b5-1 SellΔOwn -11.1%
2026-02-19
$258,329
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 SellΔOwn -11.1%
|
2026-02-19 | $258,329 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-19 | $163,288 | S | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
Zoghbi Huda Y
• Director
10b5-1 SellΔOwn -12.2%
2026-02-19
$233,066
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 SellΔOwn -12.2%
|
2026-02-19 | $233,066 | S | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
Zoghbi Huda Y
• Director
10b5-1 SellΔOwn -10.3%
2026-02-19
$172,324
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 SellΔOwn -10.3%
|
2026-02-19 | $172,324 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-19 | $125,512 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-19 | $43,994 | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-02-19 | $3,160 | S | Form 4 |